A retrospective study to assess the impact of universal 13-valent pneumococcal conjugate vaccine immunization on pediatric empyema rates and pathogen during an 8-year period
Latest Information Update: 04 Nov 2019
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
Most Recent Events
- 04 Nov 2019 New trial record
- 15 Oct 2019 Results published in the Pediatric Infectious Disease Journal.